Associations between Reoperations and Psychological Factors after Contralateral Risk-Reducing Mastectomy: A Two-Year Follow-Up Study.
Introduction. The aim of the study was to investigate associations between reoperations after contralateral risk-reducing mastectomies (CRRM) and emotional problems, body image, sexuality, and health related quality of life (HRQoL) in women with breast cancer and hereditary high risk. Patients and Methods. Patients scheduled for CRRM with breast reconstruction between 1998 and 2010 completed questionnaires, comprised of SF-36, the Hospital Anxiety and Depression Scale, the Body Image Scale, and the Sexual Activity Questionnaire, preoperatively and two years after CRRM. Data on reoperations was collected from medical charts. Results. A total of 80 women participated, with a response rate of 61 (76%) preoperatively and 57 (71%) at the two-year follow-up. At the two-year assessment, 44 (55%) patients had undergone ≥1 reoperation (reoperation group), whereas 36 (45%) had not (no reoperation group). No statistically significant differences between the groups were found for HRQoL, sexuality, anxiety, or depression. A higher proportion of patients in the "reoperation group" reported being dissatisfied with their bodies (81% versus 48%, p = 0.01). Conclusion. The results suggest associations between reoperation following CRRM with breast reconstruction and body image problems. Special attention should be paid to body image problems among women who are subject to reoperations after CRRM.
Department of Oncology-Pathology, Karolinska Institutet, 171 76 Stockholm, Sweden.
Dmytro
D
Unukovych
Department of Reconstructive Plastic Surgery, Karolinska University Hospital, 171 76 Stockholm, Sweden; Department of Molecular Medicine and Surgery, Karolinska Institutet, 171 76 Stockholm, Sweden.
Marie
M
Wickman
Department of Molecular Medicine and Surgery, Karolinska Institutet, 171 76 Stockholm, Sweden; Department of Breast and Endocrine Surgery, Karolinska University Hospital, Stockholm, Sweden.
Kerstin
K
Sandelin
Department of Oncology-Pathology, Karolinska Institutet, 171 76 Stockholm, Sweden; Department of Oncology, Karolinska University Hospital, 171 76 Stockholm, Sweden.
Brita
B
Arver
Department of Oncology-Pathology, Karolinska Institutet, 171 76 Stockholm, Sweden; Department of Oncology, Karolinska University Hospital, 171 76 Stockholm, Sweden.
Hemming
H
Johansson
Department of Oncology-Pathology, Karolinska Institutet, 171 76 Stockholm, Sweden.
Yvonne
Y
Brandberg